Hyponatremia during Administration of Tacrolimus in an Allogeneic Bone Marrow Transplant Recipient [2]

International Journal of Hematology

Volumn 78, Issue 3, 2003, Pages 268-269

  Azuma, Taichi ^a,b   Narumi, Hiroshi ^b   Kojima, Kensuke ^b   Nawa, Yuichiro ^a   Hara, Masamichi ^a  

^a EHIME PREFECTURAL CENTRAL HOSPITAL   (Japan)

^b EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

TACROLIMUS;

ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; CASE REPORT; CHRONIC MYELOID LEUKEMIA; DRUG WITHDRAWAL; FEMALE; FLUID INTAKE; GRAFT VERSUS HOST REACTION; HUMAN; HYPEROSMOLALITY; HYPONATREMIA; INAPPROPRIATE VASOPRESSIN SECRETION; LETTER; RECIPIENT; SODIUM BLOOD LEVEL;

EID: 0142057509     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02983807     Document Type: Letter

References (5)

1. Sakamoto K, Yamada K, Arita S, Hamaguchi K, Kashiwabara H, Yokoyama T. Sodium-losing nephropathy and distal tubular damage of transplant kidneys with FK506 administration. Transplant Proc. 1995;27:826-828.
2. Chan TY. Drug-induced syndrome of inappropriate antidiuretic hormone secretion. Causes, diagnosis and management. Drugs Aging. 1997;11:27-44.
3. Fung JJ, Alessiani M, Abu-Elmagd K, et al. Adverse effects associated with the use of FK506. Transplant Proc. 1991;23:3105-3108.
4. Jain AB, Fung JJ, Todo S, et al. One thousand consecutive primary orthotopic liver transplants under FK506: survival and adverse events. Transplant Proc. 1995;27:1099-1104.
5. Woo M, Przepiorka D, Ippoliti C, et al. Toxicities of tacrolimus and cyclosporine A after allogeneic blood stem cell transplantation. Bone Marrow Transplant. 1997;20:1095-1098.